Hildegard Stähle - Concepedia

Concepedia

Author

Hildegard Stähle

Boehringer Ingelheim (Germany)

Also Known As

H. STÄHLE, Hildegard Stähle

9

Publications

2.7K

Citations

8

H-Index

21

Concepts

All Affiliations

Boehringer Ingelheim (Germany)

HS

About

Hildegard Stähle is an author at Boehringer Ingelheim (Germany) specializing in pharmacotherapy, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.5K
2	Health Sciences	1	1	172
3	Biochemistry	1	1	17
4	Hepatology	1	1	172
5	Nephrology	1	1	721

Hildegard Stähle

×

8

Publications

2.7K

Citations

8

H-Index

	Year	Citations
The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects Joachim Stangier, Karin Rathgen, Hildegard Stähle, British Journal of Clinical Pharmacology	2007	880
Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate Joachim Stangier, Karin Rathgen, Hildegard Stähle, Clinical Pharmacokinetics Oral Dabigatran EtexilatePharmacological StudyMedicinePharmacotherapyNephrology	2010	721
Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly Subjects Joachim Stangier, Hildegard Stähle, Karin Rathgen, Clinical Pharmacokinetics ThrombosisCardiovascular DiseaseHealthy Elderly SubjectsMedicineHematology	2008	421
Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement Joachim Stangier, Bengt I. Eriksson, Ola E. Dahl, The Journal of Clinical Pharmacology	2005	290
Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment Joachim Stangier, Hildegard Stähle, Karin Rathgen, The Journal of Clinical Pharmacology Dabigatran EtexilatePathologyModerate Hepatic ImpairmentPharmacotherapyThrombosis	2008	172
Coadministration of Dabigatran Etexilate and Atorvastatin Joachim Stangier, Karin Rathgen, Hildegard Stähle, American Journal of Cardiovascular Drugs Molecular PharmacologyDabigatran EtexilateMedicinePhysiologyVascular Biology	2009	95
Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, With Coadministration of Digoxin Joachim Stangier, Hildegard Stähle, Karin Rathgen, The Journal of Clinical Pharmacology ThrombopoiesisThrombosisPotential ImpactPharmacological StudyDabigatran Etexilate	2011	56
Pharmacokinetics and pharmacodynamics of BIBT 986, a novel small molecule dual inhibitor of thrombin and factor Xa Eva U. Graefe-Mody, Uwe Schühly, Karin Rathgen, Journal of Thrombosis and Haemostasis ThrombopoiesisThrombosisBibt 986BiochemistryMedicine	2006	17

Page 1